PCI Biotech Holding ASA reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was NOK 88.39 million compared to NOK 72.24 million a year ago. Basic loss per share from continuing operations was NOK 2.37 compared to NOK 1.94 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 NOK | -2.91% | +0.13% | -23.63% |
1st Jan change | Capi. | |
---|---|---|
-23.63% | 5.51M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- PCIB Stock
- News PCI Biotech Holding ASA
- PCI Biotech Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2021